The global adult bovine serum market size is estimated to be valued at US$ 145.13 billion in 2024 and is expected to exhibit a CAGR of 10% over the forecast period from 2024 to 2031.

The demand for adult bovine serum is growing majorly due to the rising demand for cell culture media from biopharmaceutical companies for vaccine production, tissue engineering, stem cell research, and biologics production. The growing R&D investments in cell-based therapies, stem cell research, and drug development are also supporting the market growth.

The global adult bovine serum market is expanding significantly driven by increased collaborations between market players and research institutes. The key players are focusing on expanding their presence in emerging markets of Asia Pacific, Latin America, and Middle East & Africa through partnerships and acquisitions. This is expected to provide opportunities for adult bovine serum market growth over the forecast period.

Increasing biopharmaceutical R&D activities is one of the key factors driving the Adult Bovine Serum Market Size Growth. Biopharmaceutical companies are investing heavily in R&D of cell-based therapies, antibodies, vaccines, stem cell research, and other biologics. Adult bovine serum serves as an essential reagent for cell culturing in biopharmaceutical R&D and manufacturing processes. Growing funding from public and private organizations for cell-based research will subsequently boost the demand for adult bovine serum.

Explore more information on this topic, Please visit -